Lisa Ovesen
Family · Cincinnati, OHNPI 1932451580
Payments from drug & device makers
Across 99 payments — averaging $37.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Blueprint Medicines Corporation$657
- AbbVie$474
- Astellas Pharma US Inc$433
- Johnson & Johnson$242
- E.r. Squibb & Sons, L.L.C.$190
- Seagen Inc.$187
- plus $2K from 31 others
What the payments were for
- Consulting fees$54015%
- Food & beverage$2,61170%
- Education$57315%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Blueprint Medicines Corporation | 3 | $657 |
| AbbVie | 15 | $474 |
| Astellas Pharma US Inc | 11 | $433 |
| Johnson & Johnson | 7 | $242 |
| E.r. Squibb & Sons, L.L.C. | 2 | $190 |
| Seagen Inc. | 3 | $187 |
| Sanofi | 6 | $172 |
| Novartis | 7 | $131 |
| Gilead(2 entities) | 2 | $114 |
| Incyte Corporation | 2 | $109 |
| Pharmacosmos Therapeutics Inc. | 1 | $108 |
| Cumberland Pharmaceuticals, Inc. | 3 | $92 |
| Stemline Therapeutics Inc. | 1 | $92 |
| Genmab U.S., Inc. | 3 | $73 |
| Pfizer | 4 | $69 |
| Adaptive Biotechnologies Corporation | 3 | $67 |
| Kyowa Kirin, Inc. | 2 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $44 |
| Rigel Pharmaceuticals, Inc. | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $30 |
| Fresenius Kabi USA, LLC | 1 | $28 |
| Merck | 1 | $24 |
| Morphosys, US Inc. | 1 | $22 |
| Taiho Oncology, Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Syndax Pharmaceuticals, Inc. | 1 | $20 |
| Invivyd Inc | 1 | $20 |
| GSK | 1 | $18 |
| Beone Medicines USA, Inc. | 1 | $18 |
| Bristol Myers Squibb | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Beigene USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPDIVO$121
- RYBREVANT$120
- Monoferric$108
How this compares
$3,724 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Cincinnati
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Lindsey SpencerCincinnati$53K
- Bria BarjucaCincinnati$38K
- Jillian CowanCincinnati$20K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.